Popular Articles
Benefits Of Grapefruit

Breakthrough In The Development Of A Novel Human Antibody Platform Announced By OMT
Open Monoclonal Technology, Inc. (OMT), in collaboration with Sangamo BioSciences, Inc. (NASDAQ, SGMO), Sigma-Aldrich Corporation (NASDAQ: SIAL), The Medical College of Wisconsin, and INSERM, have announced the creation of the first targeted knockout rats as detailed in "Knockout Rats Produced via Embryo Microinjection of Designed Zinc Finger Nucleases," published in the July 24th issue of Science. The creation of rats with permanent, heritable genetic mutations is a critical milestone in the development of OMT"s novel human monoclonal antibody platform.
generic viagra online
Pfizer To Give Away 70 Of Its Most Widely Prescribed Drugs To Those Who Lost Jobs
Pfizer on Thursday announced a new program that would provide some of its existing customers access to more than 70 types of medications at no cost if they have recently been laid off or lost their prescription drug coverage, USA Today reports. The program -- called MAINTAIN, or Medicines Assistance for Those who Are in Need -- will begin July 1. To receive the drugs, individuals must show that they have been unemployed since Jan. 1 and that they no longer have prescription drug insurance. They also must prove that they cannot pay for their medications and that they were taking a medication listed under the program for at least three months prior to losing their jobs. Those who meet the eligibility requirements would receive their medications at no cost for up to one year, or until they have insurance coverage. Pfizer will accept applications through Dec. 31 (Petrecca, USA Today, 5/15).According to the AP/Detroit News, medications listed for the new patient drug-assistance program include some of Pfizer"s "top money makers," such as the anti-cholesterol drug Lipitor, the painkiller Celebrex, the fibromyalgia treatment Lyrica and the impotency treatment Viagra (Johnson, AP/Detroit News, 5/14).Ray Kerins, a spokesperson for Pfizer, declined to reveal how much the program would cost the pharmaceutical company or how many potential customers might benefit from it (Bloomberg/Miami Herald, 5/15).According to the AP/News, the program "could earn Pfizer some goodwill" after "long being a target of critics of drug industry prices and sales practices" (AP/Detroit News, 5/14). Scott Morgan, president of ad agency Brunner, said, "It goes beyond goodwill. There"s definitely a marketing strategy behind this about defending against generics and maintaining your consumer base. ... It"s a pretty savvy move" (USA Today, 5/15).
News of the day
Cardica Announces Publication Of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
Cardica, Inc. (Nasdaq: CRDC) announced that the full results of the PAS-Port system multi-center pivotal trial, known as the EPIC trial, were published in the July issue of the peer-reviewed publication The Journal of Thoracic and Cardiovascular Surgery. The PAS-Port system, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in September 2008, creates a secure connection, or anastomosis, between a vein graft and the aorta, the main artery in the human body, during coronary artery bypass grafting (CABG) procedures.
Diagnostics

Uphill Battle For Obama Sparks Comparisons To Clinton's Failed Reform Bid

"Will failing to reform health care have the same consequences for Obama"s administration as it did for Clinton"s?" CNN asks. CNN notes the similarities. "In 1994, universal health care was a key policy plan for then-President Bill Clinton. It eventually failed. Now, 15 years later, another Democratic president is taking on the challenge, but facing an uphill battle from not only from Republicans, but from members of his own party." During the Clinton effort, "Republicans decried the plan as overcomplicated and used it to tag the administration as big government-loving, tax-and-spend liberals. The plan"s failure emboldened Republicans and led to huge Democratic losses in the 1994 midterm elections, allowing the GOP to take control of Congress and stymie other Clinton initiatives. Now, 15 years later, Obama potentially faces a similar fate." Bipartisan efforts, however, could aid Obama, CNN reports, but as bipartisan talks stall or fail, battle lines are drawn. "But the battle over health care reform is weighed down by complex problems, competing interests, a $1 trillion price tag, conservative Democrats in sticker shock and Republicans sensing an opportunity to regain some of the power they lost in the 2006 congressional elections. Conservative Bill Kristol wrote in his blog that there is an opportunity to inflict political damage to the president and that opponents shouldn"t compromise: "My advice, for what it"s worth: Resist the temptation," Kristol wrote. "This is no time to pull punches. Go for the kill."" "Former Senate Majority Leader Tom Daschle, who Obama had tapped to be Health and Human Services director and the point person on health care reform before tax problems derailed his nomination, said getting health care reform passed now will be a major factor in defining Obama"s presidency. "Because he"s made it such an issue, and because he has invested so much personal time and effort, this will, more than stimulus and more than anything he has done so far, be a measure of his clout and of his success early on," Daschle was quoted in the New York Times. "And because it is early on, it will define his subsequent years"" (Hornick, 7/22). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):